Compare · head to head
Astellas Pharma vs Panion & Bf Biotech
Astellas Pharma ranks higher overall — 360 rank 100 vs 84.
Astellas Pharma leads on Value (85 vs 41). The two are close on Quality, Growth, Safety and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | Taiwan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Large | Small |
| ISIN | JP3942400007 | TW0001760007 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 100 | 84 |
| Value | 85 | 41 |
| Quality | 75 | 72 |
| Growth | 62 | 62 |
| Safety | 66 | 65 |
| Sentiment | 50 | 47 |
| Quality details | ||
| Profitability | 69 | 87 |
| Cash Truth | 81 | 58 |
Astellas Pharma vs Yuyu PharmaAstellas Pharma vs WuXi Biologics (Cayman)Astellas Pharma vs Whanin PharmAstellas Pharma vs Sino BiopharmaceuticalAdd a third stock →
Full analyses: Astellas Pharma · Panion & Bf Biotech
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100